Suppr超能文献

哮喘中使用的支气管扩张剂的杂质概况:批判性综述。

Impurity Profile of Bronchodilators used in Asthma: A Critical Review.

作者信息

Prajapati Krunal J, Kothari Charmy S

机构信息

Department of Pharmaceutical Analysis, Institute of Pharmacy, Nirma University, Sarkhej- Gandhinagar Highway, Post: Chandlodia, Via: Gota, Ahmedabad - 382 481, Gujarat, India.

出版信息

Curr Drug Discov Technol. 2018;15(4):272-304. doi: 10.2174/1570163814666170829141614.

Abstract

BACKGROUND

Asthma is defined as a heterogeneous disease usually characterized by chronic airway inflammation (GINA 2016) affecting almost 334 million people worldwide (Global asthma report 2014). Treatment of asthma with a long-acting bronchodilator is important because it reduces the symptoms that occur at night or in the early morning and it is very effective to use as a long term control medication for asthma by preventing asthmatic symptoms. The main objective of this review is to describe the impurity profile and force degradation studies for three major classes of bronchodilators namely β2-adrenoceptor agonists, muscarinic receptor antagonists and xanthine. Unidentified and potential toxic impurities are hazardous to health, so in order to increase the safety of drug therapy; impurities should be identified and determined by selective analytical methods.

METHODS

Different conditions for degradations like hydrolytic (acidic, basic and neutral), oxidative, photolytic and thermolytic have been discussed in detail for bronchodilators. Furthermore, it is discussed with the name along with number of impurities and degradants present in different matrices including its clinical implication. The name as well as structures of all the observed impurities in different bronchodilators is included, which can aid in impurity profiling. Various analytical methods, including Chromatographic techniques like TLC; HPTLC; HPLC; GC, Spectroscopic techniques like UV; IR; NMR; MS and hyphenated techniques like GC-MS; LC-MS; CE-MS; SFC-MS; LC-NMR; CENMR; LC-FTIR has been used for the identification and quantification of impurities. A general scheme has been presented for the impurity profiling.

RESULT

Nineteen articles, six patents and fifteen drugs are included in this review. In that, majority (7) of papers are based on HPLC-UV, 5 papers are based on LC-MS, 2 papers are based on LC-MS-NMR, 1 paper is based on LC-NMR, 1 paper is based on GC-MSNMR, 1 paper is based on GC-UV and 1 paper is based on TLC-UV technique for isolation and characterization of impurities. In salbutamol, 7 degradants were found by LC-MS as compare to 4 degradants by HPLC-UV. In bambuterol, 12 degradants were found by LC-MS-NMR as compare to 4 degradants by LC-MS.

CONCLUSION

After a thorough literature search, LC-MS and LC-MS-NMR techniques are found most useful for impurity profiling. In future, LC-DAD-NMR-MS, CE-ESI-FTICR- MS can also be explored for the isolation and characterization of impurities.

摘要

背景

哮喘被定义为一种异质性疾病,通常以慢性气道炎症为特征(《全球哮喘防治创议》,2016年),全球约有3.34亿人受其影响(《2014年全球哮喘报告》)。使用长效支气管扩张剂治疗哮喘很重要,因为它能减轻夜间或清晨出现的症状,并且作为哮喘的长期控制药物,通过预防哮喘症状非常有效。本综述的主要目的是描述三类主要支气管扩张剂(即β2肾上腺素能受体激动剂、毒蕈碱受体拮抗剂和黄嘌呤)的杂质概况和强制降解研究。未识别的潜在有毒杂质对健康有害,因此为了提高药物治疗的安全性,应通过选择性分析方法识别和测定杂质。

方法

详细讨论了支气管扩张剂在水解(酸性、碱性和中性)、氧化、光解和热解等不同降解条件下的情况。此外,还讨论了不同基质中存在的杂质和降解产物的名称及数量,并涉及其临床意义。列出了不同支气管扩张剂中所有观察到的杂质的名称和结构,这有助于杂质概况分析。使用了各种分析方法,包括色谱技术(如薄层色谱法、高效薄层色谱法、高效液相色谱法、气相色谱法)、光谱技术(如紫外光谱、红外光谱、核磁共振光谱、质谱)以及联用技术(如气相色谱-质谱联用、液相色谱-质谱联用、毛细管电泳-质谱联用、超临界流体色谱-质谱联用、液相色谱-核磁共振联用、毛细管电泳-核磁共振联用、液相色谱-傅里叶变换红外光谱联用)来鉴定和定量杂质。给出了杂质概况分析的一般方案。

结果

本综述纳入了19篇文章、6项专利和15种药物。其中,大多数(7篇)论文基于高效液相色谱-紫外检测法,5篇基于液相色谱-质谱联用,2篇基于液相色谱-质谱-核磁共振联用,1篇基于液相色谱-核磁共振联用,1篇基于气相色谱-质谱-核磁共振联用,1篇基于气相色谱-紫外检测法,1篇基于薄层色谱-紫外检测法来分离和表征杂质。在沙丁胺醇中,液相色谱-质谱法检测到7种降解产物,而高效液相色谱-紫外检测法检测到4种降解产物。在班布特罗中,液相色谱-质谱-核磁共振联用检测到12种降解产物,而液相色谱-质谱联用检测到4种降解产物。

结论

经过全面的文献检索,发现液相色谱-质谱联用和液相色谱-质谱-核磁共振联用技术对杂质概况分析最有用。未来,液相色谱-二极管阵列-核磁共振-质谱联用、毛细管电泳-电喷雾-傅里叶变换离子回旋共振-质谱联用也可用于杂质的分离和表征。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验